Kudchadkar Ragini R - Department of Hematology/Oncology, Emory Winship Cancer Institute

基本信息

浏览量：121

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 207 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

690Tip HERTHENA-PanTumor01: A Global Phase II Trial of HER3-DXd in Metastatic Solid Tumors

T.B. Powles, A.K. Bhatia, B. Burtness,T. Kogawa, T. Nishina, I. Nakayama,C. Fountzilas, D.R. Castillo,M. Mckean, F. Meric-Bernstam, N. Colombo,J.W. Smithy, J. Fayette, S. Chandra,D.W. Sternberg, K.H. Sullivan, S. Yueh, G. Clinthorne,R. Kudchadkar, H. Hayashi

Annals of Oncology (2024)

引用0浏览0引用

Supplemental Figure 1 from Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

Jeffrey S. Weber,Geoffrey T. Gibney,Ragini R. Kudchadkar, Bin Yu,Pingyan Cheng,Alberto J. Martinez, Jodie Kroeger,Allison L. Richards,Lori McCormick, Valerie Moberg,Heather Cronin,Xiuhua Zhao,Michael J. Schell,Yian Ann Chen

openalex（2023）

引用0浏览0引用

FcγRIIB Expressed on CD8+ T Cells Limits Responsiveness to PD-1 Checkpoint Inhibition in Cancer

Kelsey B. Bennion,Marvi Tariq,Megan M. Wyatt, Charlotte Duneton,Kirsten M. Baecher,Chrystal M. Paulos,Ragini R. Kudchadkar,Michael C. Lowe,Mandy L. Ford

Science Translational Medicineno. 710 (2023)

引用0浏览0WOSSCIENCE引用

Supplementary Table S3 from A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600–Mutant Solid Tumors

Clinton Yam, Xiaowei Xu,Michael A. Davies,Phyllis A. Gimotty, Jennifer J.D. Morrissette, Michael T. Tetzlaff,Khalida M. Wani, Shujing Liu,Wanleng Deng,Meghan Buckley, Jianhua Zhao,Ravi K. Amaravadi,Naomi B. Haas,Ragini R. Kudchadkar,Anna C. Pavlick, Jeffrey A. Sosman, Hussein Tawbi,Luke Walker,Lynn M. Schuchter,Giorgos C. Karakousis,Tara C. Gangadhar

crossref（2023）

引用0浏览0引用

Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy

Howa Yeung,Krittin J. Supapannachart,Sandy Francois,Colin H. Adler,Ragini R. Kudchadkar, David H. Lawson,Melinda L. Yushak,Afreen I. Shariff,Suephy C. Chen

JID Innovationsno. 6 (2023): 100232-100232

引用0浏览0WOS引用

Data from A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600–Mutant Solid Tumors

Clinton Yam, Xiaowei Xu, Michael A. Davies, Phyllis A. Gimotty, Jennifer J.D. Morrissette, Michael T. Tetzlaff, Khalida Wani, Shujing Liu,Wanleng Deng,Meghan Buckley, Jun Zhao, Ravi K. Amaravadi, Naomi B. Haas,Ragini R. Kudchadkar, Anna C. Pavlick, Jeffrey A. Sosman,Hussein Abdul-Hassan Tawbi,Luke Walker, Lynn M. Schuchter, Giorgos C. Karakousis,Tara C. Gangadhar

openalex

引用0浏览0引用

Data from Combined BRAF and HSP90 Inhibition in Patients with Unresectable ≪i>braf</i><sup>v600e</sup>-Mutant Melanoma

Zeynep Eroglu,Y. Ann Chen,Geoffrey T. Gibney, Jeffrey S. Weber,Ragini R. Kudchadkar,Nikhil I. Khushalani,Joseph Markowitz,Andrew S. Brohl,Leticia Tetteh,Howida Ramadan, Gina Arnone,Jiannong Li,Xiuhua Zhao,Ritin Sharma,Lancia Darville, Bin Fang,Inna Smalley,Jane L. Messina,John M. Koomen,Vernon K. Sondak,Keiran S.M. Smalley

openalex（2023）

引用0浏览0引用

Data from Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

Jeffrey Weber,Geoffrey Gibney,Ragini Kudchadkar, Bin Yu,Pingyan Cheng,Alberto J. Martinez, Jodie Kroeger,Allison Richards,Lori McCormick, Valerie Moberg,Heather Cronin,Xiuhua Zhao,Michael Schell,Yian Ann Chen

crossref（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn